Becton Dickinson & Co (NYSE:BDX)
$ 235.67 0.67 (0.29%) Market Cap: 68.11 Bil Enterprise Value: 82.95 Bil PE Ratio: 51.91 PB Ratio: 2.65 GF Score: 82/100

Becton Dickinson and Co at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 12:45PM GMT
Release Date Price: $221.34 (+0.39%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Well, good morning, everyone, and welcome to the Morgan Stanley Healthcare Conference 2020. As we enter day 3, we progress through the morning.

It's my pleasure to have with us here, as we start here in the morning on day 3, Becton, Dickinson, and 2 members of management, both Tom Polen, CEO; and Chris Reidy, CFO; and then Kristen is hanging out there somewhere with a smiley face on the strip there.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

So we're going to dispense with my normal progression here. You guys have gotten used to these last 3 days talking about COVID upfront. I want to get with Tom's strategy here to start off our conversation. And Tom, I -- we've talked about this a little bit off-line, but I've covered the company almost 2 decades. It's dating myself a little bit there. I think investors have always appreciated the durability of Becton, Dickinson, the consistency of Becton, Dickinson. And I think in the last 6 to 8 quarters, they feel

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot